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The semaphorin proteins are among the best-studied families of guidance cues, con-
tributing to morphogenesis and homeostasis in a wide range of tissue types. The major
semaphorin receptors are plexins and neuropilins, however other receptors and co-
receptors are capable to mediate signaling by semaphorins. These guidance proteins
were originally identified as growth cone “collapsing factors” or as inhibitory signals,
crucial for nervous system development. Since those seminal discoveries, the list of func-
tions of semaphorins has rapidly grown. Over the past few years, a growing body of
data indicates that semaphorins are involved in the regulation of the immune and vas-
cular systems, in tumor growth/cancer cell metastasis and in neural circuit formation.
Recently there has been increasing emphasis on research to determine the potential
influence of semaphorins on the development and homeostasis of hormone systems
and how circulating reproductive hormones regulate their expression and functions.
Here, we focus on the emerging role of semaphorins in the development, differen-
tiation and plasticity of unique neurons that secrete gonadotropin-releasing hormone
(GnRH), which are essential for the acquisition and maintenance of reproductive com-
petence in all vertebrates. Genetic evidence is also provided showing that insufficient
semaphorin signaling contributes to some forms of reproductive disorders in humans,
characterized by the reduction or failure of sexual competence. Finally, we will review
some studies with the goal of highlighting how the expression of semaphorins and
their receptors might be regulated by gonadal hormones in physiological and pathological
conditions.
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SEMAPHORINS AND THEIR RECEPTORS
Semaphorins are one of the largest protein families of phylogeneti-
cally conserved guidance cues and have been extensively studied in
a variety of species, including Caenorhabditis elegans, Drosophila,
zebrafish, rodents, and humans. More than 20 semaphorin cod-
ing genes have been identified named and grouped into eight
classes according to their structural homologies and phylogenetic
relationships, including invertebrates (Classes 1 and 2), verte-
brates (Classes 3–7), and viral semaphorins (Class V) [Figure 1;
(1, 2)].
All semaphorins are characterized by the presence of a sema
domain, important for dimerization and binding specificity with
the receptors, followed by a PSI (plexins, semaphorins, and inte-
grins) domain and a C terminus domain, which confers class
specific features (3–5).
The main receptors of semaphorins are the plexins, which are
their high affinity receptors. Nine vertebrate plexins have been
identified so far, which have been grouped into four subfamilies
and show high structural homology with semaphorins as they
are characterized by the presence of a sema domain (Figure 1)
[reviewed by (6)]. Some secreted semaphorins also require the
presence of obligate co-receptors, neuropilins (Nrp-1/Nrp-2),
which function as the ligand-binding partner in co-receptor com-
plexes for both plexins and vascular endothelial growth factor
receptors (VEGFRs) (7, 8) (Figure 1) [reviewed by (9–11)].
Moreover, some semaphorins exert their effect by binding to
various holoreceptor complexes associated to plexins. It is the case
for different tyrosine kinase receptors like Met (12–14), which also
possess a sema homologous domain, ErbB2 (15), and the VEGFR2
(16) but also extracellular matrix receptors like alpha and beta
integrins (17, 18).
Although the function of semaphorins and their receptors was
first acknowledged in the development of the nervous system,
these molecules are widely expressed both inside and outside
the nervous system [reviewed by (9, 19–22)]. The involvement
of semaphorins and plexins in diverse biological processes, such
as the development of the nervous and cardiovascular systems,
the function of the immune system, and pathological processes
such as tumor progression, has also been extensively reviewed
(10, 11, 21, 23, 24). Here, we will highlight recent advances in
our understanding of the molecular mechanisms underlying the
effects of semaphorins on the motility, survival, and axonal plas-
ticity of neurons that secrete gonadotropin-releasing hormone
(GnRH).
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FIGURE 1 | Schematic representation of the protein structure of
semaphorins and their receptors. Semaphorins are represented in their
classification into eighth classes. Class 1 and 2 semaphorins are found in
invertebrates. Class 3–7 semaphorins are found in vertebrates. Both
semaphorins and plexins are characterized by Sema domains. Additional
domains present in semaphorins and plexins include PSI domains (plexin,
semaphorin, and integrin) and immunoglobulin (Ig)-like domains. The structural
conserved domains are drawn in different shapes and colors as indicated in
the figure. Domains abbreviations: PSI, plexin semaphorin integrin; IPT, Ig-like
Plexin Transcription factors; Ig-like, immunoglobulin like; CUB, complement
C1r/C1s, Uegf, Bmp1; FV/VIII, coagulation factor V/VIII homology like; MAM,
meprin like; GPI, glycosylphosphatidylinositol.
SEMAPHORINS IN GUIDANCE OF GnRH NEURONAL
MIGRATION
In vertebrates, the GnRH decapeptide regulates the secretion
of luteinizing hormone and follicle-stimulating hormone, which
govern the onset of puberty, gametogenesis, and estrous cycling,
from anterior pituitary gonadotropes (25). During postnatal
life, GnRH – secreting neurons are integral members of the
hypothalamic-pituitary-gonadal axis. However, during embryonic
development, these cells originate from an extracerebral region,
namely the nasal placode (26), and migrate to the hypothala-
mus apposed to olfactory-vomeronasal nerves (VNNs) (27, 28).
Alterations in the development of this system or the secretion
of GnRH are associated with hypogonadotropic hypogonadism
(HH) in humans, a condition characterized by the reduction or
failure of sexual competence (29). Unraveling the genetic path-
ways involved in the regulation of GnRH system development is
crucial to understanding the basis of its pathogenesis in human
reproductive disorders and formulating novel therapies.
Cell migration plays an essential role in tissue formation during
development. The forebrain is one of the most intricate regions of
the mammalian brain, and complex migratory movements are
required to generate the extraordinary degree of organization
observed in this neural structure. Defects in neuronal migration
during the development of the forebrain lead to severe learning
and cognitive deficits. Understanding how cell migration occurs
in the forebrain is therefore essential to discerning the mechanisms
underlying its normal and pathological development (30). Abnor-
mal neuronal migration also occurs in diseases that ultimately
affect reproduction. For example, in humans, several monogenic
disorders leading to idiopathic hypogonadotropic hypogonadism
(IHH) are a consequence of the disruption of GnRH neuronal
ontogeny/migration (29). The migration of GnRH neurons from
the nasal placode, where they are born (27, 28), to the postna-
tal preoptic area and hypothalamus constitutes one of the best-
characterized examples of axonophilic migration in the forebrain
(31). To reach their final destination, these neurons migrate along
the nasal septum, cross the cribriform plate under the olfactory
bulb, and traverse the forebrain, migrating along vomeronasal
(VMN) axons (Figure 2A).
The full repertoire of molecular cues regulating the migratory
process and precise targeting of GnRH neurons to the hypothala-
mus has not been completely elucidated. The putative underlying
mechanisms involve different classes of signaling molecules, and
the list of potential candidates has lengthened during the last
decade (26, 32, 33). Another emergent theme from work on vari-
ous axonal and cell migration guidance cues is that the expression
and function of their receptors is under tight molecular control.
Such control allows the spatiotemporal regulation of the respon-
siveness of growth cones to guidance cues. However, even the large
number of molecules already identified likely underestimates the
complexity of the potential interactions involved. Indeed, GnRH
neurons spatially and temporally travel across areas (the nasal
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FIGURE 2 |The GnRH neuronal migratory route. (A) Schematic
representation of the head of a mouse embryo at E14.5, depicting the
scaffold of vomeronasal/terminal nerve fibers along which GnRH cells
migrate from the nose to the ventral forebrain region. (B) Schematic
depicting the expression pattern of different semaphorins across the
GnRH migratory pathway. (C) Mechanisms of action of the indicated
semaphorins on GnRH cell motility and/or vomeronasal axonal
navigation. Abbreviations: VNN, vomeronasal nerve; cx, cerebral
cortex; ob, olfactory bulb; nm, nasal mesenchyme; oe, olfactory
epithelium; vno, vomeronasal organ; n/fb j, nasal/forebrain junction;
aob, accessory olfactory bulb; mob, main olfactory bulb; vfb, ventral
forebrain.
region, nasal/forebrain junction, and forebrain; Figure 2) that con-
tain a variety of guidance molecules and factors. In addition, many
molecules defy anatomical boundaries by being expressed in mul-
tiple areas and may produce different responses depending on the
receptor complexes expressed by GnRH neurons as a function of
time (embryonic stage) and space (anatomical localization).
During embryonic development, several semaphorins are
expressed all along the GnRH migratory route (Figure 2B) (14, 34–
41), prompting several investigators to study the potential role
of semaphorins in GnRH neuronal migration. Although the reg-
ulation of semaphorin receptors remains incompletely under-
stood, recent studies have begun to provide more insight into the
sophisticated molecular mechanisms that allow for the diversifi-
cation and spatiotemporal control of semaphorin responsiveness
in developing GnRH neurons and olfactory/vomeronasal axons.
SEMAPHORIN 4D
Semaphorin 4D (Sema4D) is a membrane-bound semaphorin that
can also be proteolytically released (“shed”) into the extracellular
space in an active form (42, 43). An intriguing aspect of neural
circuit development is that a relatively small number of proteins
set up the wiring of a vast number of neuronal connections. Accu-
mulating evidence indicates that mechanisms exist to diversify the
effects of guidance proteins, allowing them to mediate this large
number of wiring events. How do neurons diversify their responses
to semaphorin signaling? One way this goal is achieved is through
the ability of individual semaphorins to function as attractive or
repulsive guidance cues by activating different receptor complexes
on the target cell. One such mechanism has been elucidated for
Sema4D, which, in addition to functioning as a collapsing signal
for axonal growth cones (44), has previously been shown to induce
chemotaxis in epithelial and endothelial cells, and functions as a
proangiogenic factor through the coupling its receptor PlexinB1
with the hepatocyte growth factor (HGF) receptor Met tyrosine
kinase (12, 13, 45).
PlexinB1 is highly expressed in the developing nasal placode
and on olfactory axons and GnRH cells during prenatal develop-
ment (14), whereas Sema4D is present in the nasal mesenchyme,
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although its expression is higher in the nasal/forebrain junction
and in the developing forebrain. Besides those regions, a recent
study showed that olfactory ensheathing cells, which surround
GnRH neurons and provide them with an important microenvi-
ronment for their migration during development, express Sema4D
transcript as well (46).
PlexinB1-deficient mice exhibit a defect in the migration of
GnRH neurons that leads to a reduction of GnRH neurons in the
adult brain. Postnatal day-3 tissues show a decrease in GnRH neu-
rons in the caudal region of the forebrain and an increase in GnRH
neurons in rostral brain regions as a consequence of this migratory
defect, which affects the normal embryonic development of these
neuroendocrine cells. Interestingly, it has been recently shown
that reproduction is also impaired in PlexinB1-ligand, Sema4D
knock-out mice as a consequence of a significant decrease in
GnRH hypothalamic expression and/or reduced ovarian follicle
maturation observed in these mutants (47).
In addition, Sema4D promotes directional migration in
immortalized GnRH cells by coupling PlexinB1 with the activation
of the Met tyrosine kinase [Figure 3A, reprinted with permission
from (14)]. In that study, no abnormalities were observed in the
development or organization of olfactory axons, which suggests
that the observed migratory defect may be cell-autonomous.
SEMAPHORIN 7A
The pleiotropic nature of semaphorins is particularly evident
for Semaphorin7A (Sema7A), the only glycophosphatidylinosi-
tol (GPI)-linked member of the semaphorin family [reviewed
in (48)]. Sema7A has been extensively studied in the context of
immune function (18) and cancer biology (49–51), and a few
reports have addressed its role in neuronal development as well (17,
52–54). Sema7A binds to PlexinC1 to decrease integrin-mediated
cell attachment and spreading (49), and its interaction with β1-
integrin induces integrin clustering and the activation of MAPK
FIGURE 3 | Semaphorin 4D and 7A directly regulate the motility of
GnRH cells. (A) Sema4D promotes directional migration in immortalized
GnRH cells, GN11, by coupling Plexin B1 with the activation of the
hepatocyte growth factor (HGF) receptor Met tyrosine kinase. Left panel,
representative images of a Boyden’s chamber assay showing that GN11 cells
migrated through 8µm membrane pores, attracted by 5 nM Sema4D or
0.5 nM HGF added to the lower chamber. Cells that migrated to the other
side of the filter were stained with the nuclear marker DAPI; scale bar,
50µm. Right panel, GN11 cells were infected with a lentiviral construct
encoding for a Met shRNA sequence (shRNA Met) or for a mismatched Met
shRNA (shRNA cntr), and for the GFP sequence. Virtually all GN11 cells were
infected and expressed GFP. Scale bar, 10µm. Western blot analysis of Met
protein levels in total cell lysates demonstrated that, in Met shRNA – infected
cells, Met was silenced. The graph represents the quantitative data of
Boyden’s chamber experiments. shRNA cntr cells or shRNA Met cells were
treated with 5 nM Sema4D or 0.5 nM HGF. GN11 cells in which Met was
silenced were unable to migrate toward a Sema4D gradient. Results are
expressed as mean±SEM. ***P <0.0001 from two-way ANOVA.
(B) Representative images from time-lapse videos at different time points
show GN11 neurons migrating farther onto Sema7A-coated stripes than onto
Sema7A(KGE)-coated stripes as a consequence of increased persistence.
The movement of individual cells was recorded during 6 h and plotted.
(C) Schematic representation of Sema7A function on the GnRH migratory
behavior: Sema7A is expressed along the developing olfactory/vomeronasal
axons and acts on GnRH neurons increasing adhesion and persistent
migration through β1-integrin binding and activation. Expression of PlexinC1
in GnRH neurons switches off their migratory response to Sema7A.
Reprinted with permission from (14, 40).
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pathways (17). We have also recently reported a role for Sema7A
in the regulation of GnRH cell motility (40). Sema7A is expressed
along the GnRH migratory route during mouse embryonic devel-
opment, with high levels of expression observed in the nasal pit,
where these cells begin their migratory process, and along the
olfactory/vomeronasal axonal scaffold. In addition GnRH cells
differentially express the Sema7A receptors β1-integrin and Plex-
inC1 as a function of their migratory stage: at early stages of their
migratory route, GnRH neurons only express β1-integrin, whereas
they begin to express PlexinC1 during subsequent developmental
stages and at anatomical sites at which these cells terminate their
migration (i.e., in the ventral forebrain). Semaphorin signaling is
multifaceted, and a subset of these ligands (e.g., Sema4D, Sema6D,
and Sema7A) has been shown to elicit integrin activation/cell-
substrate adhesion, axonal outgrowth, or cell chemotaxis under
distinct conditions (19). Although the molecular mechanisms
responsible for these antagonistic activities are not completely
understood, they seem to involve distinct signaling pathways that
depend on the targeted cells and the different components of
semaphorin receptor complexes. For example, Sema7A stimulates
the rapid phosphorylation of FAK and ERK1/2 in immortalized
GnRH cells and increases the directional migration of these cells
in a β1-integrin-dependent manner [Figures 3B,C, reprinted with
permission from (40)]. In contrast, the overexpression of PlexinC1
in GnRH neurons leads to reduced migration in the presence of
Sema7A (40). This switch may be essential for proper guidance
of migrating neurons into the hypothalamus. It is unknown how
PlexinC1 expression is induced in migratory GnRH neurons. One
possibility is that molecular cues presented by intermediate targets
such as the cribriform plate regulate this receptor switch.
In vivo, the loss of Sema7A impacts the migration of GnRH
neurons, resulting in a significant reduction in the GnRH neu-
ronal population in the brains of adult Sema7A-deficient mice,
as well as reduced gonadal size and altered fertility (40). Con-
sistent with these findings, the conditional inactivation of the
Sema7A receptor, β1-integrin, in GnRH neurons results in a phe-
notype that largely resembles that of Sema7A knockdown animals
(55). A very interesting aspect of this study is the finding that
male reproductive function is not affected by the disruption of
β1-integrin signaling in GnRH neurons, in spite of the compa-
rable decrease in the size of the GnRH neuronal population of
both male and female GnRH:Cre;Itgb1loxP/loxP mice when com-
pared with controls (30% reduction). However, the extent of the
reduction in GnRH neuronal projections is sexually dimorphic,
being milder in male than in female mutant mice (33% reduction
in males versus 70% reduction in females). Several reports indi-
cate that gonadal steroids are capable of modulating the expression
of different classes of guidance molecules, and thus directing the
formation of sexually dimorphic circuits by influencing axonal
guidance and synaptogenesis in addition to neurogenesis and cell
migration, differentiation, and death (56, 57).
SEMAPHORIN-3A AND -3F
Semaphorins either bind to plexins directly or, in the case of
class 3 semaphorins (Sema3s), bind to neuropilins (Nrps), which
act as ligand-binding semaphorin co-receptors. The inclusion of
additional modulatory co-receptors in the semaphorin receptor
complex could provide these receptors with unique signaling prop-
erties (21). Two class 3 semaphorins, Sema3A, and Sema3F, are
expressed in and around the developing olfactory system (34, 38).
The specific co-receptors of these class 3 semaphorins, Nrp-1, and
Nrp-2, are expressed on sensory neurons in the main and acces-
sory olfactory epithelia of rodents and zebrafish (34, 36, 38, 58).
Members of the PlexinA subfamily are concomitantly expressed
in the olfactory system, with the robust expression of PlexinA1 in
the vomeronasal organ (VNO) and VNNs (59).
The abnormal accumulation of GnRH neurons has also been
observed in the nasal compartment of Nrp-2 knock-out mice,
and Nrp-2 has been characterized as the receptor for secreted
Sema3F (60). This migratory defect potentially reflects defascicu-
lation problems that affect the olfactory/vomeronasal axons (36,
60) that guide GnRH neurons along their migratory path. Inter-
estingly, consistent with these findings, it has been reported that
Nrp-2-deficient mice are typically infertile (36, 61).
Sema3A is a secretory protein with repulsive effects on pri-
mary olfactory axons expressing the co-receptor Nrp-1 (37, 62,
63). The role of semaphorins in the navigation of vomeronasal
axons and embryonic GnRH cells remains unclear, but previous
studies in rodents have shown that migratory GnRH cells are mor-
phologically associated with Nrp-1-immunoreactive axons and
are themselves immunoreactive (64, 65). We have recently con-
firmed these findings in E14.5 mouse embryos and extended
them to a 9-week-old human fetus using immunohistofluores-
cence experiments (66). Notably, the caudal branch of the VNN,
which accompanies GnRH cells along their intracerebral path, also
expresses Nrp-1.
In a series of genetic mouse models and in vitro experi-
ments, it has recently been shown that the development of the
GnRH system relies on Sema3A signaling through Nrp-1 and
Nrp-2 (64–66). Mice lacking Sema3A or semaphorin signaling
through both Nrps show phenotypical features associated with
fetal X-linked Kallmann’s Syndrome (KS) (67), i.e., the accumu-
lation of GnRH neurons and vomeronasal axons at the dorsal
surface of the cribriform plate (64–66). Additionally, DiI axonal
labeling at E14.5 shows the abnormal projection of the VNN
into the ventral forebrain in mutant embryos lacking a func-
tional semaphorin-binding domain in Nrp-1 [Nrp-1sema/sema;
Figures 4A–D, Figures 4C,D are reprinted with permission from
(66)]. Considerable abnormal cell migration is seen in these
mutants as a consequence of the aberrant projections of the VNN
(66). Incidentally, in conditional mutant mice lacking Nrp-1 in
only GnRH neurons (GnRH:cre; Nrp-1loxP/loxP mice), the distri-
bution of these cells between the nose and the brain at E14.5
is normal, as is the number of these cells in the adult brain
(66), thus confirming that the defective migration seen in Nrp-
1sema/sema embryos is not a cell-autonomous trait but rather a
consequence of the misrouting of the VNNs into the ventral
forebrain (Figures 4A–D).
In addition to binding secreted semaphorins, the Nrps are
recognized co-receptors for vascular endothelial growth factor
(VEGF) (68–70), which is a key regulator of angiogenesis in
health and disease (71, 72) and a critical molecule for vascular
development (73, 74). It has recently been shown that Sema3A-
mediated axonal guidance takes place in cooperation with the
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FIGURE 4 |The defective migration of Nrp-1sema/sema embryos is not a
cell-autonomous trait. (A,B) Defects in olfactory and vomeronasal axons as
well as GnRH cell migration in Nrp-1sema/sema mutant mice. The vomeronasal
nerve extends across the medial aspect of the olfactory bulb and projects
both dorsally to the accessory olfactory bulb and caudally to the ventral
forebrain (vfb). In mutant mice, fibers in the caudal branch are scarce when
compared with wild-type mice. (C,D) Sagittal sections of the rostral and
ventral forebrain regions at E14.5, immunostained for GnRH (green,
arrowheads) and the olfactory/vomeronasal marker, peripherin (red). Note the
abnormal distribution of GnRH-immunoreactive cells in the Nrp-1sema/sema
mouse [(D), arrowheads]. Other abbreviations: VNN, vomeronasal nerve; cx,
cerebral cortex; ob, olfactory bulb; nm, nasal mesenchyme; oe, olfactory
epithelium; vno, vomeronasal organ; n/fb j, nasal/forebrain junction; aob,
accessory olfactory bulb; mob, main olfactory bulb; vfb, ventral forebrain.
Scale bars: (C,D), 50µm; insets, 20µm. Adapted from Ref. (66), with
permission.
alternative Nrp-1 ligand, VEGF164, which mediates neuronal
survival through neuronal, but not endothelial, Nrp-1 expression,
to ensure that migrating GnRH neurons reach the brain (64). This
study challenges two widely held models, which suggest that (1) the
lack of a catalytic intracellular domain forces Nrp-1 to use KDR,
the main VEGF receptor in blood vessels, as a co-receptor for the
transduction of VEGF signals (75) and (2) KDR is the main VEGF
receptor involved in the promotion of neuronal survival (76–78).
In contrast to these models, Cariboni and colleagues have observed
that VEGF164 signaling in GnRH neurons does not require KDR,
which instead promotes the survival of migrating GnRH neurons
via the co-activation of ERK and AKT signaling pathways through
Nrp-1.
It is widely accepted that the vascular role of Nrp-1 reflects
the loss of VEGF rather than Sema3A signaling, as supported by
the fact that mice expressing a mutant Nrp-1 that is only capable
of binding VEGF, but not semaphorins, do not exhibit vascular
defects (79). Whether neuronal VEGF acts through unconven-
tional and previously unsuspected signaling pathways is still a
matter of investigation.
SEMAPHORIN MUTATIONS IN HUMAN FORMS OF
REPRODUCTIVE INSUFFICIENCY
The use of animal models has been tremendously helpful in show-
ing that semaphorin signaling is crucial for the development,
migration, survival, and maturation of the GnRH system, and that
various forms of reproductive insufficiency involve mutations in
several genes of the semaphorin family.
Isolated GnRH deficiency, termed central hypogonadism, is an
inheritable yet underestimated disorder characterized by absent or
incomplete sexual maturation and low circulating gonadotropin
and sex steroid levels but otherwise normal pituitary func-
tion/imaging (80, 81). The disease can be associated with either
a normal sense of smell (normosmic idiopathic central hypog-
onadism, nICH) or with anosmia/hyposmia (KS), and in both
cases, anomalies in the embryonic development of the olfactory
and GnRH neuronal system have been described.
Mutations affecting at least 17 disease-genes have been asso-
ciated with the onset of nICH/KS (82): anosmin-1 (or KAL1),
fibroblast growth factor receptor-1 (FGFR1), fibroblast growth
factor 8 (FGF8), GnRH-1 and GnRH receptor (GnRHR), nasal
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embryonic LHRH Factor (NELF), G-protein-coupled recep-
tor 54 (GPR54)/kisspeptin receptor (KISS-R) and kisspeptin1
(KISS-1), prokineticin-2 (PROK2) and prokineticin receptor-
2 (PROKR2), chromodomain helicase DNA-binding protein-
7 (CHD7), neurokinin-B (TAC3) and neurokinin-B receptor
(TAC3R), heparan sulfate 6-O-sulfotransferase 1 (HS6ST1), WD
protein interacting with EMX1 transcription factor (WDR11),
SEMA3A and more recently SOX10 (83). However, these muta-
tions account for only 30% of nICH/KS patients (84), and current
efforts thus concentrate on the identification of other genes that
could contribute to these disorders.
One research strategy is based on the histopathological exami-
nation of targeted mutant mice that could reproduce the human
KS phenotype. Using this strategy, we have recently shown that
Nrp-1sema/sema mutant mice, which lack the semaphorin-binding
domain in Nrp-1, exhibit a KS-like phenotype, and genetic
evidence shows that insufficient semaphorin-3A signaling con-
tributes to the KS phenotype in humans (66). We identified eight
different mutations in the Sema3A gene in 24 of the 386 KS patients
studied (i.e., approximately 6%). Interestingly, the mutations were
consistently observed in the heterozygous state, and five patients
carried additional heterozygous mutations in PROKR2, PROK2,
KAL1, or FGFR1. These results thus identify Sema3A as a novel
contributory gene in KS and further substantiate the oligogenic
pattern of inheritance in this developmental disorder (85, 86).
Young and colleagues have also reported a large deletion in
Sema3A associated with KS in the heterozygous state in two sib-
lings and their clinically affected father (87). However, these find-
ings do not support autosomal dominant Mendelian inheritance
in the analyzed family, and suggest that another, as yet unidenti-
fied, genetic hit is associated with the Sema3A haploinsufficiency
that results in this disease phenotype (66).
A mutation in another class 3 semaphorin, Sema3E, has
also been reported in an individual affected by CHARGE syn-
drome (88). CHARGE syndrome, which includes eye coloboma,
heart malformations, atresia of the choanae, retardation of
growth/development, genital anomalies, and ear abnormalities, is
caused by mutations in CHD7 (89). CHARGE patients may display
anosmia and/or hypogonadism, which are features that overlap
with IHH and KS. Similarly, some IHH/KS patients also display
partial CHARGE features. Therefore, it has been hypothesized that
IHH/KS represents a milder allelic variant of CHARGE syndrome,
which has been supported by the identification of heterozygous
CHD7 mutations in nICH/KS individuals (89, 90).
SEMAPHORINS AND THE PLASTICITY OF ADULT HORMONE
SYSTEMS
Blood vessels and axons employ similar mechanisms and fol-
low common guidance cues for growth and navigation during
embryonic development (91, 92). Blood vessels influence axonal
trajectories to permit them to reach the appropriate destinations
(93). In the adult brain, blood vessels communicate with neurons
and glia to meet physiological demands (94). Endothelial cells are
ideally positioned to sense peripheral inputs and to convey signals
that could influence neuronal structure and synaptic plasticity.
However, whether these cells are capable of influencing axonal
plasticity in the mature central nervous system remains largely
unknown. Recent evidence suggests that semaphorins are con-
stitutively expressed in the postnatal brain and may be involved
in neuronal plasticity and nervous system physiology (95). Sem-
aphorins are also expressed in endothelial cells during vascular
development (96). Interestingly, as elaborated in the previous
sections, semaphorins act as guidance factors during the migra-
tion of GnRH neurons (14, 40, 60, 65, 66), which retain a high
degree of plasticity in the mature brain (97). As the final common
element in the central control of gonadotropin secretion, GnRH
neurons, which project into the hypothalamic median eminence
and release the neurohormone into a specialized capillary network
for delivery to the anterior pituitary (98), are affected by numer-
ous regulatory homeostatic and external factors to provide levels of
fertility appropriate to the organism. For instance, GnRH neurons
undergo extensive axonal growth toward the vascular wall during
critical time windows in adulthood, such as at the onset of the
preovulatory surge, when massive GnRH release occurs to induce
ovulation (97) (Figure 5). They are thus an ideal system for ana-
lyzing the complex relationships involved in neurosecretion and
morphological plasticity as well as the function of specific mole-
cules in the homeostasis of the adult nervous system (97, 99, 100).
Emerging data from our group shows that this periodic sprouting
FIGURE 5 | Structural plasticity of the GnRH nerve terminals and
tanycytic end-feet in the median eminence of the hypothalamus during
diestrus and proestrus. The schematic highlights the causal relationships
during the different phases of the ovulatory cycle with changes respectively
in GnRH secretion, ovarian histology, and circulating sex hormones levels.
Changes in circulating gonadal steroids are responsible for the neuro/glial
structural plasticity of the median eminence. During proestrus, GnRH nerve
endings (blue) sprout toward the basal lamina delineating the pericapillary
space (pink, Cap), with which they eventually make direct contact, while
tanycytes retract. In diestrus, under conditions of low gonadotropin output,
GnRH-secreting axon terminals are distant from the pericapillary space and
tanycytes enwrap GnRH nerve endings, thus impairing access of the
neurohormone to the pituitary portal circulation.
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of GnRH axon terminals is under the control of specific sema-
phorins, which thus play a pivotal role in orchestrating the central
control of reproduction (101, 102). Altogether, these findings raise
the intriguing possibility that semaphorins may play important
and unexpected roles in the adult neural plasticity that underlies
key physiological processes, such as reproduction.
REGULATION OF SEMAPHORINS EXPRESSION IN THE
PITUITARY-GONADAL AXIS
The expression of semaphorins, plexins, and neuropilins is consis-
tent with a prominent role for these molecules in the development
and function of the hypothalamic-pituitary-gonadal system. The
pituitary consists of three lobes: the neural lobe, the intermediate
lobe, and the anterior lobe. The neural lobe is derived from dien-
cephalic tissue, and the anterior and intermediate lobes from an
invagination of the oral ectoderm called Rathke’s pouch. During
pituitary development, the expression of Sema7A is most pro-
nounced in Rathke’s pouch, whereas it is strongly expressed in the
intermediate and anterior lobes at later developmental stages (39).
In contrast, PlexinC1 is largely confined to the neural area of the
pituitary, with only weak expression observed in the intermediate
lobe at the late embryonic stage and not at all at the postnatal or
adult stages.
Outside the central nervous system, fluctuations in reproduc-
tive hormones play a well-established role in the maintenance
of body homeostasis. For instance, ex vivo data have shown that
Sema4D is involved in the maturation of ovarian follicles in mice
(103). Sema4D and its receptor PlexinB1 are both expressed in
the mouse ovary in vivo mostly in the granulosa cells. The finding
that Sema4D increases after hormonal treatment suggests follicu-
lar auto-regulation of the plexin/semaphorin system. However, the
mechanism by which Sema4D/PlexinB1 system affects follicular
growth and steroidogenesis requires further clarification.
An analysis of Sema4D−/− and PlexinB1−/− mice and of
mice expressing a dominant-negative form of RhoA specifically
in osteoblasts has revealed an osteosclerotic phenotype in these
mutants (104). Interestingly, this phenotype is strictly dependent
on ovarian function (circulating estrogens) as an ovariectomy
suppresses the bone resorption phenotype in Sema4D−/− mice
(47), thus suggesting that Sema4D expression might be under
the control of circulating gonadal hormones. This hypothesis is
supported by previous studies, which have demonstrated that sem-
aphorins and their receptors expressions are regulated by steroid
hormones in physiological and pathological conditions. Pavelock
and coworkers provided direct evidence for the expressions of
Nrp-1 and Nrp-2 transcripts in uterine tissue and they have
shown that the levels of these neuropilins mRNAs are respec-
tively progesterone- and estrogen-dependent (105). The regulated
expression and differential localization of Nrp-1 and Nrp-2 in
the rat uterus suggest that these receptors may participate in
hormonally regulated changes occurring throughout the female
reproductive cycle (105).
Class 3 semaphorins, Sema3B and Sema3F, are secreted pro-
teins that regulate angiogenesis, tumor growth, and metastasis
by binding to their transmembrane receptor complex consist-
ing of plexins and neuropilins (23). Interestingly, a significantly
reduced expression of Sema3B (83 kDa), Sema3F (90 kDa), and
plexin-A3 was observed in human ovarian cancer cell lines when
compared with normal human ovarian surface epithelial cells
(106). The treatment of tumor cells with luteinizing hormone,
follicle-stimulating hormone, estrogen, and progesterone induced
significant changes in Sema3B and Sema3F expression (106),
implying that gonadotropin- and/or estrogen-mediated mainte-
nance of Sema3 expression could control ovarian cancer angio-
genesis and metastasis. These findings have important clinical
ramifications as they may explain why some of these tumors
become more prevalent around the perimenopausal and post-
menopausal periods of women. The same research group has also
provided compelling evidence that Sema3B, Sema3F, and plexin-
A3 were expressed strongly in normal endometrial tissues, whereas
grade-dependent decreases were found in endometrial carcinomas
(107). Moreover, treatment of cancer cells with progesterone and
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] for a period of 72 h
induced a significant upregulation of these semaphorins as well
as inhibited growth of cancer cells by increasing caspase-3 activity
(107).
Besides hormonal signaling, recent studies have demonstrated
that different classes of growth factors might also regulate sema-
phorins’ expression. Fibroblast growth factor 8 (FGF8) has been
shown to repel midbrain dopaminergic neuron (mDAN) axons
that extend through the diencephalon (108). This repulsion is
mediated by Sema3F, since the expression of Sema3F is up-
regulated by ectopic expression of FGF8 and Sema3F repels mDAN
axonal growth (108).
Another study showed that Sema7A expression is stimulated by
transforming growth factor-beta1 (TGF-β1) in the murine lung,
with Sema7A being a critical regulator of tissue remodeling in
TGF-β1-induced pulmonary fibrosis (109).
It is likely that the some growth factors might also be under
the control of hormonal signaling. Whether these hormones reg-
ulate semaphorins expression directly and/or indirectly through
growth factors modulation in neuronal and non-neuronal adult
tissues will require future investigation.
CONCLUSION
Semaphorin signaling plays a pivotal role in nervous system devel-
opment and neural network assembly, and has been shown to
influence cellular morphology in a large variety of systems. In
this review, we have focused on factors and receptors belonging
to this diverse family of guidance cues and their influence on the
development and function of multifaceted hormonal tissues, with
an emphasis on neuroendocrine systems. These activities underlie
complex developmental processes, such as the migration of neu-
rons that control fertility from the nose to the brain, the wiring of
neuroendocrine networks and the genetic bases of some forms of
reproductive disorders. The recent identification of mutations in
semaphorin genes in patients with developmental neuroendocrine
deficiencies associated with infertility illustrates the importance of
semaphorins in this process. Furthermore, semaphorin expression
persists in adulthood, and it has been proposed that these signals
play an important role in the plasticity of the neuroendocrine sys-
tems that defend homeostatic set points to enable the survival of
individuals and species. The identification of semaphorins and
their associated receptors as participants in both the development
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and functional plasticity of hormone systems creates new avenues
of investigation in endocrinology and neuroendocrinology.
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